The CD163/IL‐6/Stat3 pathway is suggested to be critical in protumor TAMs, however, macrophage‐mediated cancer cell proliferation was not affected by anti‐IL‐6R antibody (unpublished data). This evidence concerns the gene CD163 and cancer.